Results 231 to 240 of about 1,847,810 (404)

ICTP: A NEW INDEX OF BONE RESORPTION IN NEWBORN [PDF]

open access: bronze, 1993
Giuliana Trifirò, G Motta
openalex   +1 more source

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

open access: yesArthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized mice. [PDF]

open access: yesNat Commun
Xie Q   +11 more
europepmc   +1 more source

Selection of DNA Aptamers Against Parathyroid Hormone for Electrochemical Impedimetric Biosensor System Development

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT This work presents the pioneering development of an aptamer‐based electrochemical biosensor for real‐time monitoring of parathyroid hormone (PTH) levels, with a focus on intraoperative assessment during parathyroid surgery. It introduces, for the first time, the selection and characterization of aptamers targeting distinct segments of the PTH ...
Reza Didarian   +5 more
wiley   +1 more source

Impact of elevated sclerostin levels on bone resorption : unravelling structural changes and mineral metabolism disruption. [PDF]

open access: yesBone Joint Res
Rodríguez-Ortiz ME   +20 more
europepmc   +1 more source

Relationship between the alveolar bone resorption and calcium regulating factors in calcium deficient rats

open access: gold, 1988
Hideaki Qgura   +4 more
openalex   +1 more source

Effect of hydration schedules on dose‐limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims The aim of this study was to determine if head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin chemoradiotherapy and short hydration (SH) experience less dose‐limiting toxicity (DLT) and receive more cisplatin than those with medium hydration (MH) or long hydration (LH).
Anouk W. M. A. Schaeffers   +10 more
wiley   +1 more source

Bone marrow adipogenic lineage precursors are the major regulator of bone resorption in adult mice. [PDF]

open access: yesBone Res
Lu J   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy